Identifying Wearable Biomarkers to Monitor Dietary Intake
Launched by IMPERIAL COLLEGE LONDON · Apr 30, 2024
Trial Information
Current as of November 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how our bodies respond to food intake by looking for specific physical changes, known as biomarkers. Researchers want to develop a new way to accurately measure what and how much people eat, moving beyond traditional methods like food diaries, which can be unreliable. The study will involve healthy adults who will eat two different meals—one high in calories and one low—and researchers will monitor their body changes, such as skin temperature and heart rate, during these meals. They will also take blood samples to see how the body processes the food.
To participate, you need to be between 18 and 65 years old, have a body mass index (BMI) between 18 and 30, and be willing to give consent and follow the study rules. The study will take place over two visits, each lasting about two hours, at a clinical research facility. This research could help create a wearable tool in the future that helps people better understand their eating habits and health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female
- • Age between 18-65 years (inclusive)
- • Body mass index (BMI) of 18-30 kg/m2
- • Willingness and ability to give written informed consent.
- • Willingness and ability to understand, to participate and to comply with the study requirements
- Exclusion Criteria:
- • Outside of specified age and BMI range
- • Chronic medical conditions including for eating disorders, diabetes, obesity, hypertension, cancer, acute infectious disease, renal disease, cardiovascular disease, and chronic gastrointestinal condition.
- • Taking part in another research study or donating any blood in the last 3 months
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, United Kingdom
Patients applied
Trial Officials
Mingzhu Cai, PhD
Study Chair
Nutrition Research Section, Imperial College London
Mayue Shi, PhD
Principal Investigator
Department of Electrical and Electronic Engineering, Imperial College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported